GO:0003909 DNA ligase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003909 DNA ligase activity catalyzes formation of a phosphodiester bond between a 3'-hydroxyl end of one DNA chain and a 5'-phosphate end of another, using ATP or NAD+ as an energy source.
• Eukaryotic cells express multiple DNA ligases (LIG1, LIG3, LIG4) that are specialized for DNA replication, base excision repair, and non-homologous end joining.
• DNA ligase IV, in complex with XRCC4 and XLF, is the principal ligase for non-homologous end joining of DNA double-strand breaks, and its dynamic assembly is coordinated with end processing factors.
• Defects in DNA ligase IV cause Ligase IV syndrome, a rare immunodeficiency and radiosensitivity disorder.
• Altered DNA ligase III activity underlies the phenotype of the CHO EM9 mutant, linking ligase function to cellular sensitivity to DNA-damaging agents.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of DNA ligase genes in repair, replication, and disease.
Description
DNA ligase activity (GO:0003909) is a fundamental molecular function that seals breaks in the DNA backbone by forming a phosphodiester bond between a 3'-hydroxyl group and a 5'-phosphate group, a reaction that requires an energy source such as ATP or NAD+. This activity is essential for nearly every DNA transaction, including replication, repair, and recombination, because it restores the continuity of the DNA strand after polymerase or nuclease action. In eukaryotes, multiple DNA ligases with distinct but partially overlapping roles ensure that different repair and replication pathways can be completed efficiently. For researchers, DNA ligase activity is both a mechanistic hub and a therapeutic target, as its dysfunction or misregulation is associated with human disease, including immunodeficiency and cancer predisposition. Understanding the genes, structures, and regulatory layers that control DNA ligase activity is therefore central to molecular biology and translational research.
DNA ligase activity At A Glance
| GO ID | GO:0003909 |
|---|---|
| GO term | DNA ligase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalysis of phosphodiester bond formation between a 3'-hydroxyl and a 5'-phosphate end of DNA, using ATP or NAD+ |
| EC number | 6.5.1.1 (DNA ligase (ATP)) and related EC entries for NAD+-dependent ligases |
| Cofactors | ATP or NAD+ as energy source |
| Substrates | DNA strands with a 3'-OH and a 5'-phosphate at a nick or break |
| Representative genes | LIG1, LIG3, LIG4 in mammals |
| Related diseases | Ligase IV syndrome, Bloom syndrome, and other genome instability disorders |
What Is GO:0003909?
DNA ligase activity (GO:0003909) is defined as the catalysis of phosphodiester bond formation between the 3'-hydroxyl end of one DNA chain and the 5'-phosphate end of another DNA chain, driven by an energy source such as ATP or NAD+. This activity is a molecular function that enables the joining of DNA ends generated during replication, repair, and recombination, and it is carried out by a family of enzymes known as DNA ligases.
Why Is DNA ligase activity Important in Cell Biology?
DNA ligase activity is indispensable for genome maintenance because it completes the sealing step of DNA replication, base excision repair, nucleotide excision repair, and non-homologous end joining. Without ligation, single-strand breaks and double-strand breaks persist, leading to replication fork collapse, chromosomal rearrangements, and cell death. The importance of this activity is underscored by human disorders caused by ligase defects, such as Ligase IV syndrome, which features immunodeficiency and radiosensitivity, and by altered ligase activity in Bloom syndrome cells. Moreover, DNA ligases are attractive targets for drug discovery in oncology and infectious disease, and they are widely used as tools in molecular cloning and diagnostics.
• DNA ligase activity is required to seal nicks during DNA replication and repair, making it essential for genome stability.
• It is the final step of non-homologous end joining, the dominant pathway for repairing DNA double-strand breaks in mammalian cells.
• Defects in DNA ligase IV cause Ligase IV syndrome, characterized by immunodeficiency and radiosensitivity.
• Altered DNA ligase III activity in the CHO EM9 mutant links ligase function to cellular sensitivity to DNA-damaging agents.
• DNA ligase activity is reduced or dysregulated in cells from Bloom syndrome patients, connecting ligation to genome instability disorders.
• Eukaryotic DNA ligases are differentially expressed and localized, allowing specialized roles in replication and repair.
• DNA ligases are essential tools in molecular biology, including cloning, sequencing library preparation, and diagnostics.
• Novel ligases such as R2D ligase expand the catalytic repertoire of DNA ligases and enable new biotechnological applications.
• Pharmacological inhibition of DNA ligases is explored as a strategy to sensitize cancer cells to DNA-damaging therapies.
• CRISPR-based models of ligase genes allow causal testing of their roles in repair, development, and disease.
What Happens During DNA ligase activity?
Step 1: Substrate recognition and nick binding
In simple terms: The ligase finds a broken spot in DNA and holds the two ends together.
DNA ligases recognize nicks or breaks in duplex DNA where a 3'-hydroxyl group and a 5'-phosphate group are properly positioned. The enzyme binds the DNA and aligns the ends for catalysis, a step that is critical for fidelity and is influenced by the local DNA structure and accessory proteins. In non-homologous end joining, the ligase IV complex is recruited to double-strand breaks through interactions with XRCC4 and XLF, and its dynamic assembly is coordinated with end-processing factors.
Step 2: Adenylation of the ligase
In simple terms: The ligase activates itself by attaching an AMP molecule.
DNA ligases use ATP or NAD+ to form a covalent enzyme-AMP intermediate, releasing pyrophosphate or nicotinamide mononucleotide. This adenylation step is conserved across eukaryotic and prokaryotic ligases and primes the enzyme for transfer of AMP to the 5'-phosphate end of the DNA. The reaction requires a divalent metal ion, typically Mg2+, and the adenylated state is a key regulatory checkpoint.
Step 3: AMP transfer to the 5'-phosphate
In simple terms: The AMP tag is moved onto the DNA end, making it ready to react.
The adenylated ligase transfers AMP to the 5'-phosphate group at the nick, forming a 5'-phosphoanhydride intermediate and releasing the enzyme. This activated DNA end is then poised for nucleophilic attack by the 3'-hydroxyl group. The reaction is highly specific for DNA ends with the correct chemistry, and misaligned or damaged ends are poor substrates.
Step 4: Phosphodiester bond formation and sealing
In simple terms: The two DNA ends are joined together, and the break is sealed.
The 3'-hydroxyl group attacks the activated 5'-phosphate, forming a phosphodiester bond and releasing AMP. This step completes the ligation reaction and restores the continuity of the DNA strand. In non-homologous end joining, ligation is the final step after end processing and is essential for repair of double-strand breaks.
Step 5: Release and turnover
In simple terms: The ligase lets go of the sealed DNA and can be reused.
After ligation, the enzyme releases the sealed DNA product and can undergo additional rounds of adenylation and catalysis. The turnover rate and processivity vary among ligases and are influenced by accessory factors and post-translational modifications. Dysregulation of this cycle can lead to persistent DNA breaks and genome instability.
Key Genes Involved in GO:0003909 DNA ligase activity
The following genes encode DNA ligases and key accessory proteins that directly support DNA ligase activity in eukaryotic cells.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LIG1 | ATP-dependent DNA ligase that seals nicks during DNA replication and excision repair | Model for replication-associated ligation and cancer susceptibility |
| LIG3 | ATP-dependent DNA ligase involved in base excision repair and mitochondrial DNA maintenance | Target for studying repair defects and the CHO EM9 phenotype |
| LIG4 | ATP-dependent DNA ligase that completes non-homologous end joining with XRCC4 and XLF | Causal gene for Ligase IV syndrome and radiosensitivity |
| XRCC4 | Scaffold protein that stabilizes and stimulates LIG4 | Essential for non-homologous end joining and genome stability |
| NHEJ1 (XLF) | Accessory factor that promotes LIG4-mediated ligation | Modulates end joining efficiency and fidelity |
| APTX | Aprataxin, removes adenylate groups from DNA ends to facilitate ligation | Linked to neurodegenerative disease and repair defects |
| POLB | DNA polymerase that generates ligatable nicks during base excision repair | Upstream of ligation in repair pathways |
| PCNA | Sliding clamp that coordinates replication and repair factors including ligases | Context for replication-coupled ligation |
| FEN1 | Flap endonuclease that creates ligatable nicks during replication and repair | Upstream of ligation in Okazaki fragment processing |
| RPA | Single-stranded DNA-binding protein that supports repair and ligation | Accessory factor in repair complexes |
| BRCA1 | DNA repair factor that influences pathway choice and ligation | Context for double-strand break repair |
| BRCA2 | Homologous recombination factor that competes with non-homologous end joining | Pathway choice and ligation outcomes |
| TP53BP1 | Factor that promotes non-homologous end joining and ligation | Regulates repair pathway selection |
| ATM | Kinase that coordinates DNA damage responses and repair | Upstream regulator of ligation-dependent repair |
| DNA2 | Nuclease/helicase that processes ends for ligation | Replication and repair end processing |
| R2D ligase (bacterial) | Novel DNA ligase with DNA-to-RNA ligation activity | Biotechnological tool for RNA ligation |
How Is DNA ligase activity Regulated?
DNA ligase activity is regulated at multiple levels, including transcription, post-translational modification, and interaction with accessory proteins. In non-homologous end joining, the dynamic assembly of the ligase IV complex with XRCC4 and XLF is coordinated with end processing and is influenced by the DNA damage response kinases ATM and DNA-PK. Cellular levels of DNA ligase activity can also change in response to DNA damage and in disease states, as shown by altered ligase III activity in the CHO EM9 mutant and reduced ligase activity in Bloom syndrome cells. These regulatory layers ensure that ligation is temporally and spatially coupled to the appropriate repair or replication pathway.
DNA ligase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LIG4 | Ligase IV syndrome with immunodeficiency and radiosensitivity | Knockout or point-mutation cell lines to test repair and V(D)J recombination |
| LIG3 | Altered activity in CHO EM9 mutant and repair deficiency | Knockout and rescue models to measure DNA damage sensitivity |
| LIG1 | Replication-associated ligation defects and genome instability | Knockout cells to study Okazaki fragment processing |
| BLM (context) | Bloom syndrome with altered ligase activity | Patient-derived cells and isogenic controls for ligase assays |
| XRCC4 | Non-homologous end joining deficiency and radiosensitivity | Knock-in of patient variants to test ligation efficiency |
Ligase IV syndrome
Biallelic mutations in LIG4 cause Ligase IV syndrome, a rare disorder characterized by immunodeficiency, radiosensitivity, and growth retardation. The disease links defective non-homologous end joining and DNA ligase activity to impaired lymphocyte development and genome instability. Experimental models of LIG4 deficiency show increased sensitivity to ionizing radiation and defective V(D)J recombination.
Bloom syndrome and genome instability
Bloom syndrome is a genome instability disorder caused by mutations in BLM, and cells from affected patients show altered DNA ligase activity compared with normal cells. This connection suggests that ligase function is part of the broader network that maintains replication fork stability and repair. Studying ligase activity in Bloom syndrome cells can reveal how replication stress contributes to disease phenotypes.
DNA repair deficiency and chemosensitivity
The CHO EM9 mutant has altered DNA ligase III activity and exhibits hypersensitivity to DNA-damaging agents, providing a cellular model for repair deficiency. This phenotype highlights how reduced ligase function can sensitize cells to chemotherapy and radiation. Such models are valuable for testing repair-targeted therapeutic strategies.
Cancer and therapeutic targeting
DNA ligases are attractive targets in oncology because their inhibition can impair repair of DNA damage induced by chemotherapy or radiotherapy. Non-homologous end joining, which depends on DNA ligase IV, is a major resistance mechanism in cancer cells, and its dynamic assembly is being explored as a target. Small-molecule inhibitors of DNA ligases are under investigation as radiosensitizers and chemosensitizers.
From DNA ligase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of LIG4 impair non-homologous end joining? | LIG4 knockout cell line with DNA damage sensitivity assays |
| Does a patient variant reduce ligase activity? | Point-mutation knock-in of the variant and biochemical ligation assays |
| Can wild-type ligase rescue a repair defect? | Knock-in or overexpression of wild-type LIG4 in knockout background |
| Where does ligase III localize during repair? | Tagged knock-in of LIG3 with fluorescent tag and imaging |
| What is the effect of ligase overexpression on chemosensitivity? | Overexpression cell model treated with DNA-damaging agents |
| Which genes buffer ligase loss? | CRISPR library screening in ligase-knockout background |
How to Study the DNA ligase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro ligation assay | Enzymatic sealing of nicked DNA | Kinetic and inhibitor studies |
| Cell survival assay | Sensitivity to DNA-damaging agents | Validation of repair defects |
| Fluorescence imaging | Assembly of ligase complexes at damage sites | Dynamic repair studies |
| RNA sequencing | Expression of ligase genes and pathway changes | Regulatory and compensatory analysis |
| Proteomics | Protein interactions and post-translational modifications | Complex composition studies |
| CRISPR knockout | Loss-of-function phenotypes | Causal gene testing |
| CRISPR knock-in | Variant-specific effects | Patient mutation modeling |
| CRISPR library screening | Genome-wide modifiers of ligase loss | Synthetic lethality discovery |
Biochemical ligation assays
DNA ligase activity can be measured in vitro using oligonucleotide substrates with a nick or break, followed by gel electrophoresis to detect sealed products. These assays allow kinetic analysis of ATP- or NAD+-dependent ligation and are used to compare wild-type and mutant enzymes. They are also used to test inhibitors and to characterize novel ligases such as R2D ligase.
DNA damage sensitivity assays
Cell survival assays after treatment with ionizing radiation or DNA-damaging drugs reveal the functional impact of ligase deficiency. The CHO EM9 mutant, for example, shows hypersensitivity to DNA-damaging agents due to altered ligase III activity. These assays are standard for validating repair defects in knockout or knock-in models.
Repair complex assembly and imaging
Fluorescence microscopy and live-cell imaging of tagged ligases and accessory factors can reveal dynamic assembly at DNA damage sites. Non-homologous end joining factors, including ligase IV, XRCC4, and XLF, form dynamic assemblies that can be tracked in real time. These methods connect molecular function to spatial organization in the nucleus.
Genomic and proteomic profiling
RNA sequencing and proteomics can quantify ligase expression and identify interaction partners in different cell states. Such profiling helps define how ligase activity is regulated and which pathways compensate when it is lost. These approaches are complementary to targeted biochemical assays.
How CRISPR Can Be Used to Study GO:0003909 DNA ligase activity
Knockout
CRISPR knockout of LIG1, LIG3, or LIG4 allows researchers to test the requirement for each ligase in DNA repair and replication. Knockout cells can be challenged with DNA-damaging agents to reveal sensitivity phenotypes, as seen in repair-deficient models. These models are foundational for assigning causal roles to specific ligase genes.
Point Mutation
Point-mutation knock-in of disease-associated variants in LIG4 or other ligase genes enables precise testing of how single amino acid changes affect enzyme activity and repair. Such models can distinguish loss-of-function from hypomorphic alleles and reveal genotype-phenotype relationships. They are particularly valuable for rare disease variants identified in patients.
Knock-in
Knock-in of tagged ligases, such as fluorescent or epitope-tagged LIG3, supports imaging and proteomic studies of ligase localization and interactions. Knock-in of wild-type ligase into a knockout background can rescue phenotypes and confirm specificity. These approaches link molecular function to cellular behavior.
Overexpression
Overexpression of DNA ligases can test gain-of-function effects, including altered chemosensitivity and repair capacity. Overexpression models are useful for studying how excess ligase activity affects pathway choice and genome stability. They also support drug screening for ligase inhibitors.
How EDITGENE Supports DNA ligase activity Research
Researchers studying DNA ligase activity-related genes often need to determine whether a candidate gene is causally involved in repair, replication, or disease phenotypes, and CRISPR-based models provide the most direct way to test this. By combining knockout, point-mutation, knock-in, and overexpression strategies, it is possible to dissect the contribution of each ligase and its accessory factors to genome maintenance.
Contact EDITGENE today to design your custom CRISPR model for DNA ligase activity research.
Frequently Asked Questions About DNA ligase activity
What is DNA ligase activity?
DNA ligase activity (GO:0003909) is the catalysis of phosphodiester bond formation between a 3'-hydroxyl end and a 5'-phosphate end of DNA, using ATP or NAD+ as an energy source.
What genes are involved in DNA ligase activity?
Key genes include LIG1, LIG3, and LIG4, which encode ATP-dependent DNA ligases with specialized roles in replication and repair.
Which DNA ligase is used in non-homologous end joining?
DNA ligase IV, in complex with XRCC4 and XLF, is the principal ligase for non-homologous end joining.
What diseases are linked to DNA ligase activity?
Ligase IV syndrome is caused by LIG4 mutations, and altered ligase activity has been observed in Bloom syndrome cells and the CHO EM9 mutant.
How is DNA ligase activity measured?
It is commonly measured using in vitro ligation assays with nicked DNA substrates and gel electrophoresis, as well as cell survival assays after DNA damage.
What is the difference between LIG1, LIG3, and LIG4?
LIG1 functions in replication and excision repair, LIG3 in base excision repair and mitochondrial DNA maintenance, and LIG4 in non-homologous end joining.
Can CRISPR be used to study DNA ligase genes?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of ligase gene function in repair and disease.
What is Ligase IV syndrome?
Ligase IV syndrome is a rare disorder caused by LIG4 mutations, featuring immunodeficiency and radiosensitivity due to defective non-homologous end joining.
Are there DNA ligases with unusual activities?
Yes, R2D ligase is a novel DNA ligase with DNA-to-RNA ligation activity, expanding the known catalytic repertoire.
Why is DNA ligase activity important for genome stability?
It seals nicks and breaks generated during replication and repair, preventing persistent DNA damage and chromosomal rearrangements.
Conclusion
DNA ligase activity (GO:0003909) is a central molecular function that seals DNA breaks and is required for replication, repair, and recombination. The diversity of eukaryotic ligases and their accessory factors ensures that different DNA transactions are completed with high fidelity, and defects in these enzymes cause human disease such as Ligase IV syndrome. Continued research using CRISPR-based models and biochemical assays will clarify how ligase activity is regulated and how it can be targeted therapeutically.
References
- 1. Gundesø SE et al.. 2024. R2D ligase: Unveiling a novel DNA ligase with surprising DNA-to-RNA ligation activity.. Biotechnol J 19(3):e2300711 PMID: 38528369
- 2. Liu L et al.. 2025. Dynamic assemblies and coordinated reactions of non-homologous end joining.. Nature 643(8072):847-854 PMID: 40500445
- 3. Lasko DD et al.. 1990. Eukaryotic DNA ligases.. Mutat Res 236(2-3):277-87 PMID: 2204827
- 4. Tomkinson AE et al.. 1997. Mammalian DNA ligases.. Bioessays 19(10):893-901 PMID: 9363683
- 5. Lohman GJ et al.. 2011. DNA ligases.. Curr Protoc Mol Biol Chapter 3:Unit3.14 PMID: 21472697
- 6. Chistiakov DA et al.. 2009. Ligase IV syndrome.. Eur J Med Genet 52(6):373-8 PMID: 19467349
- 7. Mezzina M et al.. 1989. DNA ligase activity in human cell lines from normal donors and Bloom's syndrome patients.. Nucleic Acids Res 17(8):3091-106 PMID: 2726453
- 8. Ljungquist S et al.. 1994. Altered DNA ligase III activity in the CHO EM9 mutant.. Mutat Res 314(2):177-86 PMID: 7510367
